ARROW Endurance™ Extended Dwell Peripheral Catheter System Receives FDA Market Clearance
July 29 2015 - 5:30PM
Business Wire
Catheter System Designed to Provide Peripheral
Vascular Access “When a PIV is Not Enough and a PICC is Too
Much”
Teleflex Incorporated (NYSE:TFX), a global provider of medical
devices for critical care and surgery, announced today that its
ARROW Endurance™ Extended Dwell Peripheral Catheter System received
market clearance from the U.S. Food and Drug Administration
(FDA).
The new device is a peripheral catheter system in which the
catheter is cleared by the FDA to dwell up to 29 days. The extended
dwell catheter enables hospitals to avoid using multiple PIVs to
achieve longer dwell times while also avoiding the extra clinical
risks and expenses associated with a peripherally inserted central
catheter (PICC). The intravascular catheter is intended for
short-term use (up to 29 days) to permit delivery of infusion
therapies, pressure monitoring, high pressure injection (325 psi
max.), and withdrawal of blood.
“The ARROW Endurance™ Extended Dwell Peripheral Catheter System
is yet another offering from Teleflex that helps vascular access
professionals provide the right line for the right patient at the
right time,” said Jay White, president of Teleflex's Vascular
Access Division. “This is the ideal solution when patients need IV
therapy for more than the few days that a traditional PIV allows
but don’t require a PICC.”
Designed to maximize performance and ease-of-use, the extended
dwell system is engineered to increase safety for clinicians and
reduce needle sticks for patients. The device contains a passive
needle safety that reduces the risk of accidental needle stick
injuries and exposure to blood. The closed system design makes it
less likely that clinicians will accidentally come in contact with
bloodborne pathogens.
Teleflex expects to launch the ARROW Endurance™ Extended Dwell
Peripheral Catheter System in the United States later this
year.
To learn more about the Arrow® Vascular portfolio from Teleflex,
please visit ArrowVascular.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Wayne, PA, Teleflex employs approximately 12,200
people and serves healthcare providers worldwide. For additional
information about Teleflex please refer to www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, Arrow, and Arrow Endurance are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates. ©
2015 Teleflex Incorporated. All rights reserved. MC-001435
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150729005018/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor
Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024